Evidence map›Paper›PMID 38674864›Full record

ArticleNutrients2024

Gut Microbiome-How Does Two-Month Consumption of Fiber-Enriched Rolls Change Microbiome in Patients Suffering from MASLD?

Karolina Kaźmierczak-Siedlecka, Dominika Maciejewska-Markiewicz, Maciej Sykulski, Agata Gruszczyńska, Julia Herman-Iżycka, Mariusz Wyleżoł, Karolina Katarzyna Petriczko, Joanna Palma, Karolina Jakubczyk, Katarzyna Janda-Milczarek and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Editorial: Hot topics in diabetes and steatotic liver disease.Frontiers in clinical diabetes and healthcare · 2026
    Article
  4. Article
  5. Dietary fibre and the gut microbiome: implications for glucose homeostasis.Current opinion in clinical nutrition and metabolic care · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Karolina Kaźmierczak-SiedleckaDepartment of Medical Laboratory Diagnostics-Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 80-211 Gdansk, Poland.ORCID 0000-0002-0283-1436
Dominika Maciejewska-MarkiewiczDepartment of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland.
Maciej SykulskiDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.
Agata GruszczyńskaDepartment of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Julia Herman-IżyckaGenXone S.A., ul. Kobaltowa 6, 62-002 Złotniki, Poland.
Mariusz WyleżołDepartment of General, Vascular and Oncological Surgery, Medical University of Warsaw, 02-091 Warsaw, Poland.
Karolina Katarzyna PetriczkoTranslational Medicine Group, Pomeranian Medical University, 70-204 Szczecin, Poland.
Joanna PalmaDepartment of Biochemical Sciences, Pomeranian Medical University in Szczecin, Broniewskiego 24, 71-460 Szczecin, Poland.ORCID 0000-0003-0620-3776
Karolina JakubczykDepartment of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland.ORCID 0000-0002-5853-9709
Katarzyna Janda-MilczarekDepartment of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland.ORCID 0000-0002-4548-3419
Karolina Skonieczna-ŻydeckaDepartment of Biochemical Sciences, Pomeranian Medical University in Szczecin, Broniewskiego 24, 71-460 Szczecin, Poland.ORCID 0000-0002-3430-9079
Ewa StachowskaDepartment of Human Nutrition and Metabolomics, Pomeranian Medical University, 71-460 Szczecin, Poland.ORCID 0000-0002-4009-1977
Pomeranian Medical University · PLMedical University of Warsaw · PLGdańsk Medical University · PLUniversity of Szczecin · PLWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe occurrence of metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global problem which commonly affects patients with co-existing diseases/conditions, such as type 2 diabetes and dyslipidemia. The effective treatment of MASLD is still limited; however, diet plays a significant role in its management. There are multiple beneficial properties of dietary fiber, including its ability to modify the gut microbiome. Therefore, the aim of this study was to determine the effect of the consumption of fiber-enriched rolls on the gut microbiome and microbial metabolites in patients suffering from MASLD.

methodsThe participants were recruited according to the inclusion criteria and were required to consume fiber-enriched rolls containing either 6 g or 12 g of fiber. There were three assessment timepoints, when the anthropometric and laboratory parameters were measured, and 16s on nanopore sequencing of the fecal microbiome was conducted.

resultsFirmicutes and Bacteroidetes were the most abundant phyla in the patients living with MASLD. It was demonstrated that the amount of short-chain fatty acids (SCFAs) changed after the consumption of fiber-enriched rolls; however, this was strongly associated with both the timepoint and the type of SCFAs-acetate and butyrate. Additionally, the high-fiber diet was related to the increase in phyla diversity (

conclusionsOverall, the introduction of an appropriate amount of fiber to the diet seems to be promising for patients suffering from MASLD due to its ability to create an improvement in gut microbiome-related aspects.

Indexed as

Dietary FiberFatty Acids, VolatileFecesGastrointestinal MicrobiomeAdultAgedBacteroidetesFemaleHumansMaleMiddle AgedDietary FiberFatty Acids, Volatilefibergut microbiotanonalcoholic fatty liver diseaseshort-chain fatty acids

Identifiers

PMID38674864
PMCPMC11053994
OpenAlexW4394808577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.